Steigerwald, Gordon & Koch Inc. Pfizer Inc Transaction History

Steigerwald, Gordon & Koch Inc.

$803 Million
Q1 2024

A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 239,848 shares of PFE stock, worth $6.71 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

239,848

Previous 79,736 200.8%

Holding current value

$6.71 Million

Previous $2.3 Million 189.98%

% of portfolio

0.83%

Previous 0.31%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$25.89 - $29.73 $4.15 Million - $4.76 Million	160,112 Added 200.8%	239,848 $6.66 Million
Q4 2023 Jan 16, 2024	BUY	$26.13 - $33.94 $1.51 Million - $1.96 Million	57,668 Added 261.32%	79,736 $2.3 Million
Q3 2023 Oct 11, 2023	BUY	$32.09 - $37.51 $6,097 - $7,126	190 Added 0.87%	22,068 $731,000
Q2 2023 Jul 17, 2023	BUY	$36.12 - $41.79 $17,193 - $19,892	476 Added 2.22%	21,878 $802,000
Q1 2023 Apr 19, 2023	SELL	$39.39 - $51.28 $15,834 - $20,614	-402 Reduced 1.84%	21,402 $873,000

Q4 2022 Jan 17, 2023	BUY	$41.75 - $54.5 $21,751 - $28,394	521 Added 2.45%	21,804 $0
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $20,786 - $25,374	-475 Reduced 2.18%	21,283 $931,000
Q2 2022 Jul 14, 2022	BUY	$46.53 - $55.17 $202,033 - $239,548	4,342 Added 24.93%	21,758 $1.14 Million
Q1 2022 Apr 25, 2022	SELL	$45.75 - $56.69 $9,790 - $12,131	-214 Reduced 1.21%	17,416 $902,000
Q4 2021 Jan 26, 2022	BUY	$41.32 - $61.25 $16,858 - $24,990	408 Added 2.37%	17,630 $1.04 Million
Q3 2021 Oct 18, 2021	BUY	$39.25 - $50.42 $4,239 - $5,445	108 Added 0.63%	17,222 $741,000
Q2 2021 Jul 27, 2021	SELL	$35.91 - $40.68 $10,449 - $11,837	-291 Reduced 1.67%	17,114 $670,000
Q1 2021 Apr 27, 2021	BUY	$33.49 - $37.77 $10,381 - $11,708	310 Added 1.81%	17,405 $631,000
Q4 2020 Jan 22, 2021	BUY	$33.47 - $42.56 $45,853 - $58,307	1,370 Added 8.71%	17,095 $629,000
Q3 2020 Oct 14, 2020	BUY	$31.75 - $37.25 $1,905 - $2,235	60 Added 0.38%	15,725 $577,000
Q2 2020 Jul 14, 2020	BUY	$30.12 - $36.54 $20,782 - $25,212	690 Added 4.61%	15,665 $512,000
Q1 2020 Apr 20, 2020	BUY	$27.03 - $38.62 $62,087 - $88,710	2,297 Added 18.12%	14,975 $489,000
Q4 2019 Jan 27, 2020	BUY	$32.92 - $37.36 $188,039 - $213,400	5,712 Added 82.0%	12,678 $497,000
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $64 - $84	2 Added 0.03%	6,966 $250,000
Q2 2019 Jul 15, 2019	SELL	$36.98 - $41.52 $23,926 - $26,863	-647 Reduced 8.5%	6,964 $302,000
Q1 2019 Apr 18, 2019	SELL	$37.5 - $41.2 $70,537 - $77,497	-1,881 Reduced 19.82%	7,611 $323,000
Q4 2018 Jan 18, 2019	SELL	$38.47 - $43.86 $4,924 - $5,614	-128 Reduced 1.33%	9,492 $414,000
Q3 2018 Oct 11, 2018	BUY	$34.47 - $41.81 $551 - $668	16 Added 0.17%	9,620 $424,000
Q2 2018 Sep 14, 2018	BUY	$32.98 - $35.16 $59,957 - $63,920	1,818 Added 23.35%	9,604 $348,000
Q1 2018 Sep 14, 2018	BUY	$31.91 - $37.02 $1,499 - $1,739	47 Added 0.61%	7,786 $276,000
Q4 2017 Sep 14, 2018	SELL	$33.26 - $35.29 $158,251 - $167,909	-4,758 Reduced 38.07%	7,739 $280,000
Q3 2017 Sep 14, 2018	BUY	$31.0 - $34.15 $69,719 - $76,803	2,249 Added 21.95%	12,497 $446,000
Q2 2017 Sep 13, 2018	BUY	N/A	211 Added 2.1%	10,248 $344,000
Q1 2017 Sep 13, 2018	BUY	N/A	2,396 Added 31.36%	10,037 $343,000
Q4 2016 Sep 13, 2018	BUY	N/A	38 Added 0.5%	7,641 $248,000
Q3 2016 Sep 13, 2018	BUY	N/A	531 Added 7.51%	7,603 $258,000
Q2 2016 Sep 13, 2018	BUY	N/A	13 Added 0.18%	7,072 $249,000
Q1 2016 Sep 13, 2018	BUY	N/A	425 Added 6.41%	7,059 $209,000
Q4 2015 Sep 13, 2018	BUY	N/A	100 Added 1.53%	6,634 $214,000
Q4 2014 Sep 13, 2018	BUY	N/A	6,534	6,534 $204,000

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steigerwald, Gordon & Koch Inc., based on Form 13F filings with the SEC.

News

Stay updated on Steigerwald, Gordon & Koch Inc. with notifications on news.

Account

Steigerwald, Gordon & Koch Inc. Pfizer Inc Transaction History